Kenneth S. Cohen to Chemokine CXCL12
This is a "connection" page, showing publications Kenneth S. Cohen has written about Chemokine CXCL12.
Connection Strength
0.035
-
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007 Jan; 11(1):83-95.
Score: 0.018
-
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res. 2006 Sep 15; 66(18):9054-64.
Score: 0.017